Latest Orion Pharma News & Updates

See the latest news and media coverage for Orion. We track all announcements, press releases, and industry mentions in real time, all in one place.

Orion Pharma (Orion)

Nordic pharmaceutical company developing human and veterinary medicines

orionpharma.com

Headquarters: Espoo, Finland
Company type: Public company
Number of employees: 3,500–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Orion Pharma (Orion)

In short: Orion achieved strong H1 2026 growth, secured orphan drug status for its cancer pipeline, and launched a €45 million share buyback.

Company announcements

September 4 Orion

Orion purchases 102722 shares totaling EUR 48 million last week

The acquisition fulfills part of the company announced a share buyback programme running until December 31. Total treasury holdings now reach 370,888 Class B shares.

July 17 Orion

Orion reports half-year financial results for H1 2026

Net sales rose 21.8% to EUR 939.3 million, operating profit increased 59.6%, and outlook was raised.

July 15 Orion

Orion converts 45,611 A shares into B shares

The conversion, entered into the Trade Register on 15 July 2026, adjusts the share structure and total votes.

June 23 Orion

Orion's ODM-212 granted orphan designation for malignant mesothelioma

The European Commission granted the designation based on EMA recommendation, following FDA's prior orphan drug designation.

Media coverage

September 3 Ad hoc news

Orion stock holds steady as investors look to latest H1 2026 results

Orion stock is trading calmly while investors digest the Finnish pharma group’s H1 2026 results and await the next set of earnings figures after a...

August 10 Kauppalehti

Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH ...

Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did...

July 6 AFP

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for...

July 3 Yahoo Finance

Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026

ORION CORPORATION PRESS RELEASE 3 JULY 2026 at 9.00 EEST Orion publishes Half-Year Report for January–June 2026 and holds a ...

Never miss news about Orion

Track Orion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Orion competitors & trending companies

Browse news for competitors to Orion and other trending companies.